Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
出版年份 2022 全文链接
标题
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
作者
关键词
-
出版物
CANCER TREATMENT REVIEWS
Volume 109, Issue -, Pages 102429
出版商
Elsevier BV
发表日期
2022-06-22
DOI
10.1016/j.ctrv.2022.102429
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase II study of chemotherapy in combination with telomerase peptide vaccine (GV1001) as second-line treatment in patients with metastatic colorectal cancer
- (2022) Sejin Kim et al. Journal of Cancer
- Immunopeptidomic analyses of colorectal cancers with and without microsatellite instability
- (2022) Jenna Cleyle et al. MOLECULAR & CELLULAR PROTEOMICS
- Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
- (2021) Shiwen Peng et al. mBio
- Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
- (2021) Leona Yamamoto et al. Frontiers in Oncology
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Novel Protein-Based Vaccine against Self-Antigen Reduces the Formation of Sporadic Colon Adenomas in Mice
- (2021) Elodie Belnoue et al. Cancers
- Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
- (2021) D. G. Roy et al. Nature Communications
- Efficacy finding cohort of a cancer peptide vaccine, TAS0313, in treating recurrent glioblastoma.
- (2021) Yoshiki Arakawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention
- (2021) Lauren R. Corulli et al. Frontiers in Immunology
- Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model
- (2021) Johannes Gebert et al. GASTROENTEROLOGY
- Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
- (2020) Jan Dörrie et al. Pharmaceutics
- Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
- (2020) Abishek Wadhwa et al. Pharmaceutics
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
- (2020) Qianqian Ni et al. Science Advances
- A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
- (2020) Yanina Jansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters
- (2020) Inken Salewski et al. Journal of Translational Medicine
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
- (2019) Tanner M. Johanns et al. OncoImmunology
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
- (2019) Marit M. Melssen et al. Journal for ImmunoTherapy of Cancer
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- A PD-L1-Based Cancer Vaccine Elicits Antitumor Immunity in a Mouse Melanoma Model
- (2019) Zhibing Lin et al. Molecular Therapy-Oncolytics
- A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
- (2019) Jie Chen et al. Cancers
- A large peptidome dataset improves HLA class I epitope prediction across most of the human population
- (2019) Siranush Sarkizova et al. NATURE BIOTECHNOLOGY
- Targeting the microenvironment in solid tumors
- (2018) Carmen Belli et al. CANCER TREATMENT REVIEWS
- Hitting the Target: How T Cells Detect and Eliminate Tumors
- (2018) Anthony E. Zamora et al. JOURNAL OF IMMUNOLOGY
- Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report
- (2018) Katja Sonntag et al. Journal of Translational Medicine
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
- (2016) Marios Giannakis et al. Cell Reports
- Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines
- (2016) Spencer D. Martin et al. PLoS One
- Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients
- (2015) Maria Grazia Cusi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Human Anti-CD40 Antibody and Poly IC:LC Adjuvant Combination Induces Potent T Cell Responses in the Lung of Nonhuman Primates
- (2015) Elizabeth A. Thompson et al. JOURNAL OF IMMUNOLOGY
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients
- (2015) Pierpaolo Correale et al. OncoImmunology
- DNA vaccine for cancer immunotherapy
- (2015) Benjamin Yang et al. Human Vaccines & Immunotherapeutics
- Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
- (2014) M. Rajasagi et al. BLOOD
- Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
- (2014) Sofie Wilgenhof et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
- (2014) S. D. Brown et al. GENOME RESEARCH
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
- (2014) Marius M. Strioga et al. VACCINE
- HLA-Binding Properties of Tumor Neoepitopes in Humans
- (2014) E. F. Fritsch et al. Cancer Immunology Research
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides
- (2013) Lei Diao et al. CLINICAL PHARMACOKINETICS
- Comparison of Vaccine-Induced Effector CD8 T Cell Responses Directed against Self- and Non-Self-Tumor Antigens: Implications for Cancer Immunotherapy
- (2013) S. R. Pedersen et al. JOURNAL OF IMMUNOLOGY
- HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
- (2013) Diana P. English et al. Molecular Diagnosis & Therapy
- Maraba Virus as a Potent Oncolytic Vaccine Vector
- (2013) Jonathan G Pol et al. MOLECULAR THERAPY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Whole Cell Vaccines—Past Progress and Future Strategies
- (2012) Bridget P. Keenan et al. SEMINARS IN ONCOLOGY
- The Present and Future of Peptide Vaccines for Cancer
- (2011) Craig L. Slingluff CANCER JOURNAL
- Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma
- (2011) Sofie Wilgenhof et al. JOURNAL OF IMMUNOTHERAPY
- Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer
- (2011) Neil Senzer et al. MOLECULAR THERAPY
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans
- (2011) Elena Quaglino et al. Cancers
- Parathyroid Hormone-Related Protein (PTHrP): A Key Regulator of Life/Death Decisions by Tumor Cells with Potential Clinical Applications
- (2011) Claudio Luparello Cancers
- Cellular Vaccine Approaches
- (2010) Dung T. Le et al. CANCER JOURNAL
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors
- (2010) Kanji Sato et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing
- (2008) P. J. Campbell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started